Last update 11 Jul 2024
MedImmune LLC

MedImmune LLC

Subsidiary Company|
1987|
United States
|
5,000-10,000
| NASDAQ: MEDI|

Overview

Basic Info

Introduction
MedImmune is a global biologics research and development company that specializes in creating medications for unmet medical needs. As a division of AstraZeneca, they are dedicated to exploring innovative research and novel pathways in various therapeutic areas such as respiratory, inflammation, autoimmunity, cardiovascular and metabolic disease, oncology, neuroscience, and infection and vaccines. With a strong commitment to scientific innovation and medical progress, MedImmune has been pushing the boundaries of what is possible since its establishment in 1988.

Tags

Neoplasms
Respiratory Diseases
Skin and Musculoskeletal Diseases
Monoclonal antibody
Bispecific antibody
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Monoclonal antibody20
Antibody drug conjugate (ADC)3
Bispecific antibody3
Small molecule drug3
Prophylactic vaccine2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
15
Preclinical
Phase 1 Clinical
8
8
Phase 2 Clinical
Phase 3 Clinical
3
2
Approved
Other
123
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free